Literature DB >> 16267833

Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival.

Caitlin E Hill1, Lawrence D F Moon, Patrick M Wood, Mary Bartlett Bunge.   

Abstract

Although transplanted Schwann cells (SCs) can promote axon regeneration and remyelination and improve recovery in models of spinal cord injury, little is known about their survival and how they interact with host tissue. Using labeled SCs from transgenic rats expressing human placental alkaline phosphatase (PLAP), SC survival in a spinal cord contusion lesion was assessed. Few PLAP SCs survived at 2 weeks after acute transplantation. They died early due to necrosis and apoptosis. Delaying transplantation until 7 days after injury improved survival. A second wave of cell death occurred after surviving cells had integrated into the spinal cord. Survival of PLAP SCs was enhanced by immunosuppression with cyclosporin; delayed transplantation in conjunction with immunosuppression resulted in the best survival. In all cases, transplantation of SCs resulted in extensive infiltration of endogenous p75+ cells into the injury site, suggesting that endogenous SCs may play an important role in the repair observed after SC transplantation. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16267833     DOI: 10.1002/glia.20287

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  54 in total

1.  Efficient generation of schwann cells from human embryonic stem cell-derived neurospheres.

Authors:  Lina Ziegler; Sergei Grigoryan; In Hong Yang; Nitish V Thakor; Ronald S Goldstein
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

2.  Schwann cell coculture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice.

Authors:  Xiaoyun Xu; Nicole Geremia; Feng Bao; Anna Pniak; Melissa Rossoni; Arthur Brown
Journal:  Cell Transplant       Date:  2010-11-19       Impact factor: 4.064

3.  Multiple channel bridges for spinal cord injury: cellular characterization of host response.

Authors:  Yang Yang; Laura De Laporte; Marina L Zelivyanskaya; Kevin J Whittlesey; Aileen J Anderson; Brian J Cummings; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

Review 4.  Morphological characteristics of apoptosis and its significance in neurogenesis.

Authors:  S G Kalinichenko; N Yu Matveeva
Journal:  Neurosci Behav Physiol       Date:  2008-05

5.  Combined effects of rat Schwann cells and 17β-estradiol in a spinal cord injury model.

Authors:  Zeinab Namjoo; Fateme Moradi; Roya Aryanpour; Abbas Piryaei; Mohammad Taghi Joghataei; Yusef Abbasi; Amir Hosseini; Sajad Hassanzadeh; Fatemeh Ranjbar Taklimie; Cordian Beyer; Adib Zendedel
Journal:  Metab Brain Dis       Date:  2018-04-15       Impact factor: 3.584

Review 6.  Novel combination strategies to repair the injured mammalian spinal cord.

Authors:  Mary Bartlett Bunge
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

Review 7.  Cell transplantation therapy for spinal cord injury.

Authors:  Peggy Assinck; Greg J Duncan; Brett J Hilton; Jason R Plemel; Wolfram Tetzlaff
Journal:  Nat Neurosci       Date:  2017-04-25       Impact factor: 24.884

8.  Differential effects of distinct central nervous system regions on cell migration and axonal extension of neural precursor transplants.

Authors:  Ying Jin; Karna Sura; Itzhak Fischer
Journal:  J Neurosci Res       Date:  2012-06-27       Impact factor: 4.164

9.  Transplantation of Adult Rat Schwann Cells into the Injured Spinal Cord.

Authors:  Ying Dai; Caitlin E Hill
Journal:  Methods Mol Biol       Date:  2018

10.  Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia.

Authors:  Rodolfo E Gámez Sazo; Katsumi Maenaka; Weiyong Gu; Patrick M Wood; Mary Bartlett Bunge
Journal:  Biomaterials       Date:  2012-08-17       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.